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pTo the Editor: Therapeutic hypothermia has been promoted as
n effective strategy for the preservation of life and neuropro-
ection in unconscious survivors of out-of-hospital cardiac
rrest (1–3), largely in patients age 50 years with myocardial
infarction, stroke, acute encephalopathy, near drowning, or
head injuries. Hypertrophic cardiomyopathy (HCM) is a com-
mon genetic heart disease and the most frequent cause of
youthful sudden cardiac death (4,5), which is associated with
oor outcomes after cardiac arrest (4). We report our experience
ith cardiac arrest in HCM, demonstrating the efficacy of
herapeutic hypothermia.
Databases of 2 HCM centers, the Minneapolis Heart Institute
nd Tufts Medical Center (2006 to 2010), were assessed. Seven
atients with out-of-hospital cardiac arrest treated with hypother-
ia constituted the study group (Table 1). Over the study period,
o other patient with HCM from the participating institutions
xperienced cardiac arrest.
Summary of Demographic and Clinical Characteristics of the Study GroupTable 1 Su mary of Demographic and Clinical Charact ristics of the St
Patient
#
Age at
Arrest (yrs)/
Sex
Circumstances
at Arrest
NYHA FC EF
Pre-Event Recent Pre-Event Rec
1 31/M Sitting and
talking
1 1 65 6
2 37/M Walking at
work
1 1 60 6
3 40/M‡ Eating in
restaurant§
1 1 65¶ 7
4 47/F Asleep 1 1 65 7
5 48/M Walking from
hospital to
parking
garage
following
CMR
1 1 60 6
6 57/M Walking down
stairs
1 1 50 4
7 76/M Working in
yard
1 1 60 7
*At hospital admission; based on a 15-point scale, with a score of 3 being the lowest level of respon
scale, with a score of 1 being the highest level of cerebral performance. ‡Not previously evaluated f
nearby. Measured with continuous-wave Doppler. ¶Obtained 4 h after arrest. #Presented to first E
hospital for TH; arrived at second ER 98 min after collapse; second facility instituted TH with Arctic
exception of patient #4, in whom CMR was performed 5 days after event. ††Presented to first ER
hospital for TH; arrived at second ER 146 min after collapse; second facility instituted TH with Arct
min after collapse; first ER transferred to second hospital for TH; arrived at second ER 111 min afte
arrival. §§Presented to first ER approximately 31 min after collapse; emergency medical services
to second hospital for TH; arrived at second ER 96min after collapse; second facility instituted TH wi
norepinephrine, and phenylephrine).
BB beta-blocker; BP blood pressure; CCB calcium channel blocker; CMR cardiovascular
raction; ER  emergency room; FC  functional class; FU  follow-up; LV  left ventricular; LVID  left
onsustained ventricular tachycardia; NYHA  New York Heart Association; PVC  premature ventriculaThe 7 patients ranged in age from 31 to 76 years (median 47
ears); each was asymptomatic, and 6 were men. Four patients
ad resting left ventricular outflow gradients of 45 to 70 mm
g. Maximal left ventricular wall thickness on echocardiogra-
hy ranged from 21 to 24 mm (mean 23  1.5 mm).
Hypertrophy was segmental, involving the anterior septum and
contiguous free wall or the distal (apical) portion of the left
ventricle (Patient #2). None had conventional sudden death risk
markers sufficient to warrant prophylactic defibrillator implan-
tation (5).
Cardiac events occurred while sedentary or with mild activity.
Rhythms at collapse were ventricular fibrillation (n  5), ventricular
tachycardia deteriorating to ventricular fibrillation (n  1), and
asystole (n 1; Patient #2). Bystanders (including the husband of Patient
#4) and/or emergency medical technicians initiated cardiopulmonary
resuscitation or defibrillation within 3 min in 6 patients and within 9 min
in 1 (Patient #7). Patients #3, #4, and #7 received ice packs in the
roup
Pre-Event
Medications
Maximal
LV Thickness
(mm)
LVID
(mm)
LVOT
Gradient
at Rest
(mm Hg)
24-h Holter
(Pre-Event) CMR-DE**
CCB 23 38 0 Normal Posterior
septum
and LV
free wall
None 24 53 0 Normal Distal LV:
moderate
None 24 45 57 NA Focal
CCB 21 37 45 Frequent PVCs
(3,000);
rare NSVT
Diffuse LV and
marked
BB, CCB,
warfarin
24 44 70 NA Anterior/
posterior
septum
(transmural)
CCB 21 43 50 Infrequent
NSVT
NA
BB 21 36 0 SVT and
1 couplet
Midinferior LV
wall (mild)
otor, verbal, and eye-opening categories. †At or shortly after hospital discharge; based on a 5-point
ac disease. §Accompanied by a friend who was a trained fireman; automated external defibrillator
in after collapse; first ER applied ice packs locally 52 min after collapse and transferred to second
mperature Management System 7 min after arrival. **Performed before cardiac arrest, with the
after collapse; first ER applied ice packs locally 90 min after collapse and transferred to second
emperature Management System 76 min after arrival. ‡‡Presented to first ER approximately 24
se; second facility instituted TH with Arctic Sun Temperature Management System 133 min after
lied ice packs locally 15 min after collapse; first ER maintained ice packs and transferred patient
c Sun Temperature Management System 9min after arrival. Pressors administered (epinephrine,
tic resonance; CPC Cerebral Performance Category; DE delayed enhancement; EF ejectionudy G
ent
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ventricular internal dimension; LVOT  left ventricular outflow tract; NA  not available; NSVT 
r contraction; TH  therapeutic hypothermia.
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June 14, 2011:2454–60community hospital en route to the center. The time elapsed from
collapse to spontaneous circulation ranged from 5 to 37 min (mean 19
min). Transport time from collapse to arrival at the hypothermia center
ranged from 4 to 146 min (mean 72 min).
The Glasgow Coma Scale score (6) was 3 in each patient upon
arrival at the hypothermia center, indicative of an unconscious state
without meaningful or voluntary response. The time interval from
arrival at the hospital to hypothermia initiation ranged from 7 to
204 min (mean 90 min). Elapsed time from collapse to hypother-
mia ranged from 34 to 244 min (mean 62 min).
Standard hypothermia protocols used an automated external
cooling system circulating chilled water through hydrogel en-
ergy transfer pads in 6 patients (Arctic Sun Temperature
Management System, Medivance, Inc., Louisville, Colorado) or
the endovascular infusion of chilled, sterile saline (CoolGard
3000, Zoll Medical Corporation, Chelmsford, Massachusetts)
in 1 (Patient #2). Core temperature was rapidly lowered and
maintained over 24 to 29.2 h at 31.8 to 33.1°C, followed by
rewarming at 0.5°C/h. Complications, present in 6 patients,
were most commonly pneumonia (n  5), bradyarrhythmias
n  5), and pulmonary edema (n  3).
Hospital stay ranged from 7 to 27 days (mean 15 days). A
erebral Performance Category score (7) of 1 patient, indicative
f normal cerebral function, was assigned to each patient at or
hortly after discharge. All survived, to date, 12 to 58 months
fter collapse, and are asymptomatic.
Ejection fractions measured before and after cooling did not
iffer significantly (mean 61  5% vs. 63  12%, p  0.68) and
ContinuedTable 1 Continued
Collapse
to ER
(min)
ER to
TH
(min)
Collapse
to TH
(min)
TH
(h)
TH
(°C)
GCS
Score*
CPC
Score†
29 170 199 24.0 32.0 3 1
23 204 227 24.0 33.1 3 1
98# 7# 105 26.7 32.7 3 1
146†† 76†† 222 24.0 33.0 3 1
4 30 34 24.0 33.0 3 1
111‡‡ 133‡‡ 244 29.2 31.8 3 1
96§§ 9§§ 105 27.0 33.1 3 1ere normal in 6 of the 7 patients (range 60% to 75%); cooling had
negligible effect on cardiac index and blood pressure. Each
atient received a secondary prevention defibrillator; 2 experienced
evice interventions for ventricular fibrillation 6 and 17 months after
ypothermia (Patients #4 and #6) (5). Two patients carried double
isease-causing sarcomere mutations (8): MyBPC3Gln998Glu and
NN13Arg145Trp (Patient #2) and MyBPC3Arg943Ter and
NN13Ser166Phe (Patient #5).
At present, there are virtually no data available regarding the
fficacy of therapeutic cooling in relatively young patients with
enetic heart diseases. We describe our recent experience with
atients (median age 47 years) who incurred out-of-hospital
entricular fibrillation or asystole. Each received prompt cardio-
ulmonary resuscitation or defibrillation and was unconscious
hen hypothermia began, but experienced rapid and dramatic
mprovement without significant intellectual or neurologic deficit
r impaired cardiac pump performance.
The prognosis of patients with HCM after cardiac arrest
without hypothermia) has been unfavorable, with death and/or
eurologic deficit the predominant consequence despite cardiopul-
onary resuscitation or defibrillation (4). Notably, hypothermia
as successful in this study group despite left ventricular wall
hicknesses exceeding 20 mm in all patients, outflow tract gradi-
nts 45 mm Hg in 4 patients, asystole as the initial rhythm in 1
atient, and a long delay (4 h) in cooling implementation in 1
atient.
These favorable results are probably largely related to the initial
apid response, the patients’ generally good health (and youthful
ges in 6 patients), and normal systolic function before arrest.
fter
apse
ths)
Cardiac Index (l/min/m2) BP (mm Hg)
Baseline 12 h 24 h Baseline 12 h 24 h
2 — — — 127/70 139/86 128/70
0 — — — 141/103 110/63 121/82
1 1.17 2.24 1.95 128/81 108/63 93/58
6 — — — 175/103 146/100 118/80
4 — — — 98/64 115/74 103/67
8 2.34 1.41 1.56 95/62 95/58 91/60
4 2.23 1.26 2.57 112/57 112/53 115/46FU A
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June 14, 2011:2454–60Indeed, the 100% survival of this select cohort exceeds that
anticipated in the broader population of patients treated with
hypothermia (ranging from 50% to 60%) (1,2), as well as in
competitive athletes with HCM and cardiac arrest treated only
with cardiopulmonary resuscitation and defibrillation (4).
None of our patients were considered candidates for prophy-
lactic defibrillators because of the absence of conventional risk
markers (5); notably, however, 2 had double-sarcomere mutations,
which have been associated with severe disease expression (8).
This study opens a window to novel patient subgroups that may
enefit, with respect to survival and neuroprotection, from thera-
eutic hypothermia. Our encouraging results could represent a
aradigm shift with regard to out-of-hospital cardiac arrest in
atients with HCM, and support the broader dissemination of
ypothermia as a powerful treatment strategy.
Barry J. Maron, MD
Minneapolis Heart Institute Foundation
ypertrophic Cardiomyopathy Center
20 E. 28th Street, Suite 620
inneapolis, Minnesota 55407
-mail: hcm.maron@mhif.org
artin S. Maron, MD
radley A. Maron, MD
ammy S. Haas, RN
their analysis (given that the classic Framingham Risk ScoreRobert K. Altman, MD
Stephen J. Smalley, MD
Joseph J. Doerer, MD
Mark S. Link, MD
Michael R. Mooney, MD
doi:10.1016/j.jacc.2011.03.021
lease note: This study was funded in part by a grant from the Hearst Foundations
New York, NY).
EFERENCES
1. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose
survivors of out-of-hospital cardiac arrest with induced hypothermia.
N Engl J Med 2002;346:557–63.
2. The Hypothermia After Cardiac Arrest Study Group. Mild therapeutic
hypothermia to improve the neurologic outcome after cardiac arrest.
N Engl J Med 2002;346:549–56.
3. Heard KJ, Peberdy MA, Sayre MR, et al. A randomized controlled trial
comparing the Artic Sun to standard cooling for induction of hypo-
thermia after cardiac arrest. Resuscitation 2010;81:9–14.
4. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden
deaths in young competitive athletes: analysis of 1866 deaths in the
U.S., 1980–2006. Circulation 2009;119:1085–92.
5. Maron BJ. Contemporary insights and strategies for risk stratification and
prevention of sudden death in hypertrophic cardiomyopathy. Circulation
2010;121:445–56.
6. Teasdale G, Jennett B. Assessment of coma and impaired conscious-
ness. A practical scale. Lancet 1974;13:81–4.
7. Cummins RO, Chamberlain DA, Abramson NS, et al. Recommended
guidelines for uniform reporting of data from out-of-hospital cardiac
arrest: the Utstein Style. Circulation 1991;84:960–75.8. Kelly M, Semsarian C. Multiple mutations in genetic cardiovascular disease: a
marker of disease severity? Circ Cardiovasc Genet 2009;2:182–90.Letters to the EditorCalcium Score Reclassification
How Should Baseline Risk Be Measured?
Elias-Smale et al. (1) present an excellent report examining the
reclassification potential of coronary artery calcium (CAC)
among subjects enrolled in the Rotterdam Study. They are to be
applauded for using only hard endpoints in their reclassification
analysis, as well as for calculating absolute CAC score reclas-
sification cutoffs (50 or 615 Agatston Units [AU]). In
addition, complex statistical techniques were meticulously ap-
plied and allowed for calculation of the actual 10-year event risk
(a significant strength of this report). These factors overcome
some limitations of previous reports (2), and strengthen the
argument that CAC has a practical role in reclassifying a
substantial number of intermediate-risk patients, 55% in this
study (1).
We feel it would be helpful for the authors to report the
absolute CAC score reclassification cutoffs they would have
found if they had not used the Framingham “refitted” model
(1). While the use of this refitted model seems appropriate for[FRS] led to systematic overestimation of cardiac risk in a prior
report from this cohort [3]), it limits the external validity of the
50/615 AU thresholds outside of the Rotterdam cohort.
The use of the classic FRS should, in theory, improve the end
net reclassification improvement (NRI) of this study (if this
overestimation was uniform). Importantly, it would also change
the calculated CAC score cutoffs reported, presumably reducing
both the lower and upper limits for reclassification (the relative
increase in c-statistic with the addition of CAC to FRS should
also improve, although the absolute value of 0.76 [1] should
not). These “true FRS” CAC score cutoffs would be more
applicable to future studies or even clinical practice, in that the
classic FRS will be used in these settings (and not the
Rotterdam “refitted” FRS). In summary, the whole point of
using CAC to reclassify cardiac risk is that FRS can be
inaccurate when applied in real-world practice; it seems to
defeat the purpose to “refit” the FRS to the specific study
population before performing reclassification analyses.
Finally, we would also caution that cutoff scores will always
be somewhat arbitrary in that they are only amalgamates of
average demographic risk in the whole study population and
may deteriorate in accuracy when applied to the individual
